Revenue (TTM) Chart

Historical Revenue (TTM) Data

View and export this data back to 2013. Start Trial.
Date Value
July 31, 2026 0.0847M
April 30, 2026 0.0716M
January 31, 2026 0.1204M
October 31, 2025 0.128M
July 31, 2025 0.1409M
April 30, 2025 0.1529M
January 31, 2025 0.1007M
October 31, 2024 0.1892M
July 31, 2024 0.299M
April 30, 2024 0.291M
October 31, 2023 0.611M
July 31, 2023 0.5726M
April 30, 2023 0.5149M
October 31, 2022 0.678M
July 31, 2022 0.521M
April 30, 2022 0.5608M
January 31, 2022 0.4985M
October 31, 2021 0.3395M
Date Value
July 31, 2021 0.1962M
April 30, 2021 0.1151M
January 31, 2021 0.1278M
October 31, 2020 0.1223M
July 31, 2020 1.885M
April 30, 2020 5.837M
January 31, 2020 8.317M
January 31, 2016 9.418M
October 31, 2015 7.617M
July 31, 2015 3.630M
April 30, 2015 1.118M
October 31, 2014 0.00
July 31, 2014 0.00
January 31, 2014 0.00
October 31, 2013 0.0315M
July 31, 2013 11.44M
April 30, 2013 17.40M
January 31, 2013 22.48M

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (TTM) Range, Past 5 Years

View Revenue (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (TTM) Benchmarks

View Revenue (TTM) Benchmarks
Start Trial
Xcelerate, Inc. 0.5319M
Vivos Therapeutics, Inc. 20.90M
Hinge Health, Inc. 720.06M
Anika Therapeutics, Inc. 120.65M
Enovis Corp. 2.297B